Factors associated with sustained virological response in 24‐week telaprevir‐based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 4, 2015-04 ,pp. : 387-396

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of IL28B and PNPLA3 polymorphisms on treatment outcomes in patients infected with genotype 6 hepatitis C virus

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 6, 2015-06 ,pp. : 1040-1048

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon response in genotype2

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 1, 2015-01 ,pp. : 178-183

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic variation in the interleukin‐28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1127-1134

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictive factors and virological response to interferon treatment in children with chronic hepatitis B

By Söderström Ann   Lindh Magnus   Ekholm Kajsa   Conradi Nils   Horal Peter   Krantz Marie   Hultgren Catharina   Norkrans Gunnar  

Scandinavian Journal of Infectious Diseases, Vol. 37, Iss. 1, 2005-01 ,pp. : 40-47

Informa Healthcare

Access to resources Recommend Favorite